Of note, an increased p22phox protein expression was found in patients with CKD, end stage renal disease, dialysis patients with left ventricular hypertrophy, patients with primary (essential) hypertension, Fabry disease, renal transplantation, and primary hyperaldosteronism [52,53,54,55,56]. This evidence concerns the gene CYBA and left ventricular hypertrophy.